South Korea: The use of the Pfizer vaccine has been approved

Get real time updates directly on you device, subscribe now.

Its food and medicine service South Korea announced today that it has finally approved the granting of the US-German consortium vaccine for emergency use Pfizer/BioNTech for the new coronavirus.

Seoul had already approved the use of a first batch of Pfizer product that arrived in the country last month through COVAX, a program led by the World Health Organization. These doses are already being used in the immunization campaign.

In addition, an urgent use permit was issued for the vaccine developed by the Swedish pharmaceutical industry AstraZeneca and the University of Oxford.

Get real time updates directly on you device, subscribe now.

Leave A Reply

Your email address will not be published.